Elapegademase-Lvlr
Brand name: Revcovi
Rank #435 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$19.0M
Total Cost
52
Total Claims
$19.0M
Total Cost
4
Prescribers
$365K
Cost per Claim
0
Beneficiaries
52
30-Day Fills
$4.7M
Avg Cost/Provider
13
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$19.0M of $275.65B
Top Prescribers by Cost
Top 4 prescribers of $19.0M total
🔎 Data Overview
At $364,507 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $4,738,587 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Elapegademase-Lvlr
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Christine Seroogy | Allergy/ Immunology | Madison, WI | 13 | $6.4M |
| 2 | Michael Keller | Allergy/ Immunology | Washington, DC | 15 | $5.4M |
| 3 | Taha Al-Shaikhly | Allergy/ Immunology | Hershey, PA | 11 | $3.8M |
| 4 | Terence Carey | Allergy/ Immunology | Tulsa, OK | 13 | $3.3M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 432 | Isavuconazonium Sulfate (Cresemba) | $19.2M | 3,050 |
| 433 | Paroxetine Hcl (Paroxetine Hcl) | $19.2M | 1,226,222 |
| 434 | Naloxone Hcl (Naloxone Hcl) | $19.0M | 232,875 |
| 435 | Elapegademase-Lvlr (Revcovi) | $19.0M | 52 |
| 436 | Methylprednisolone (Methylprednisolone) | $18.9M | 1,934,494 |
| 437 | Sacrosidase (Sucraid) | $18.5M | 1,517 |
| 438 | Enasidenib Mesylate (Idhifa) | $18.1M | 554 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology